Anatomic versus non-anatomic resection for intrahepatic cholangiocarcinoma in minimally invasive liver surgery: a multicentre propensity score-matched study
In brief
Intrahepatic bile duct cancer patients had similar survival after either liver resection
In 142 matched patients undergoing minimally invasive surgery, overall and disease-free survival were similar after anatomic and non-anatomic liver resection. Poor tumor differentiation and perineural invasion were linked to worse outcomes, but this retrospective study cannot rule out meaningful differences between operations; the choice should reflect tumor features, location, and surgical feasibility.
- Journal
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (Q1)
- Published
- 3 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Antonella Delvecchio, Silvio Caringi, Rebecca Marino, Remo Alessandris, Simone Conci, Laura Alaimo, et al.
- PMID
- 42994291
- DOI
- 10.1016/j.ejso.2026.112349
Why clinicians should know about it
- Picked for Surgery (paper of the day, 10 November 2026): Directly compares liver resection strategies and cancer outcomes
Abstract
BACKGROUND: The role of anatomic resection (AR) versus non-anatomic resection (NAR) for intrahepatic cholangiocarcinoma (iCCA) remains controversial, particularly in the setting of minimally invasive liver surgery (MILS). The aim of this study is to compare oncological and perioperative outcomes of AR versus NAR for iCCA. METHODS: A multicentre retrospective study was conducted in 13 Italian hepatobiliary centres. All consecutive patients undergoing MILS for iCCA were included. Patients were stratified into AR and NAR groups according to resection type. Oncological outcomes and perioperative data were compared between groups, before and after a 1:1 propensity score matching analysis (PSM). Multivariable Cox regression analyses were performed to identify independent predictors of survival and recurrence. RESULTS: A total of 421 patients were included, with 142 patients matched after PSM (71 AR vs. 71 NAR). Overall survival (OS) and disease-free survival (DFS) were comparable between groups in the matched cohort (log-rank p = 0.84 and 0.92, respectively). Multivariable Cox regression demonstrated poor tumor differentiation (G3) to be associated with worse OS (HR 2.21, 95% CI 1.03-4.75; p = 0.04). Regarding DFS, both G3 grading (HR 2.39, 95% CI 1.08-5.28; p = 0.03) and perineural invasion (HR 3.52, 95% CI 1.38-8.96; p = 0.01) were associated with recurrence. CONCLUSIONS: In this multicentre propensity score-matched cohort, no independent survival benefit of AR over NAR was demonstrated, although clinically meaningful differences cannot be excluded. Poor tumour differentiation and perineural invasion were associated with worse oncological outcomes. Resection strategy should be individualised according to tumour characteristics, location, and technical feasibility.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.